10X Genomics (TXG) PT Raised to $60 at Canaccord
Canaccord analyst Kyle Mikson raised the price target on 10X Genomics (NASDAQ: TXG) to $60.00 (from $50.00) while maintaining a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
